hoffmann roche inc licensee hormone research foundation patent synthetic version human growth hormone said entered into license agreement with eli lilly and involving lilly humatrope hormone used treat dwarfism children details license agreement were not disclosed and company officials were unavailable for comment statement from companies said lilly and roche have entered into license agreement alternative litigation south san francisco based genetech inc also markets genetically engineered human growth hormone called protropin lilly received approval from food and drug administration market human growth hormone earlier this year lilly spokesperson said company has effect licensed patent for hormone through hoffman laroche refused comment terms license agreement last september hoffman laroche and foundation sued genetech federal court california alleging its product infringed hoffman patent for synthetic hormone reuter 